Xcyte Therapies Inc. said its shares could be delisted from the Nasdaq Stock Market before the market opens Dec. 15. Shares of the Seattle-based biotech company (NASDAQ: XCYT) have traded below the $1 minimum bid price since May, when officials with Nasdaq issued a first delisting notice. The company was then given 180 days to achieve and maintain at least a $1 minimum bid price for 30 consecutive days to regain compliance. The shares opened Monday at 39 cents each.
Puget Sound Business Journal (http://seattle.bizjournals.com/seattle/stories/2005/12/12/daily5.html)